Leadership Overview
Getz Pharma has 4 executives leading key functions including financial strategy, quality operations, life sciences development, and global marketing.
Committed to advancing global health through research-driven medicine, Getz Pharma delivers high-quality, affordable pharmaceutical solutions while maintaining rigorous international manufacturing standards across diverse markets.
Committed to advancing global health through research-driven medicine, Getz Pharma delivers high-quality, affordable pharmaceutical solutions while maintaining rigorous international manufacturing standards across diverse markets.
Leadership Roles at Getz Pharma
Yahya Zakaria - Chief Financial Officer
Yahya Zakaria, the Chief Financial Officer at Getz Pharma, directs all fiscal planning and capital allocation strategies. Overseeing the financial health of the organization, the Chief Financial Officer ensures robust investment in research-driven pharmaceutical development. This leadership role involves managing complex budgetary requirements across international manufacturing sites to maintain cost-efficiency. By optimizing resource distribution, Yahya Zakaria directly impacts the ability of the company to provide affordable medicines to global markets. The Chief Financial Officer monitors economic trends to mitigate risks associated with pharmaceutical supply chains. Through precise financial oversight, Zakaria secures the long-term stability required for sustained innovation. This executive maintains alignment with the Board regarding fiscal performance and growth targets. Ultimately, the Chief Financial Officer drives the financial architecture necessary for the expansion of the branded generic portfolio, ensuring that Getz Pharma remains a competitive force in the international pharmaceutical landscape.
Adnan Siddiqui - Chief Operating Officer, Quality Operations
Adnan Siddiqui, the Chief Operating Officer, Quality Operations at Getz Pharma, architects the rigorous standards governing all manufacturing processes. Overseeing the quality assurance frameworks, the Chief Operating Officer, Quality Operations ensures every pharmaceutical product meets international safety benchmarks. This leadership role involves managing complex compliance protocols across diverse production facilities to guarantee consistent output quality. By implementing advanced testing methodologies, Adnan Siddiqui directly impacts the reliability of the branded generic medicines produced. The Chief Operating Officer, Quality Operations coordinates with regulatory bodies to maintain certifications essential for global market access. Through meticulous oversight of production workflows, Siddiqui eliminates operational inefficiencies and enhances product integrity. This executive maintains strict adherence to safety guidelines, fostering trust among healthcare providers and patients. Ultimately, the Chief Operating Officer, Quality Operations drives the operational excellence required for Getz Pharma to deliver high-quality, affordable healthcare solutions on a massive scale.
Hassan Ahmad - Chief Operating Officer - Getz Life
Hassan Ahmad, the Chief Operating Officer - Getz Life at Getz Pharma, directs the strategic development and operational execution of the life sciences division. Overseeing the specialized product pipeline, the Chief Operating Officer - Getz Life ensures the successful formulation and market introduction of innovative therapeutic solutions. This leadership role involves managing cross-functional teams to accelerate the development of new medicines. By aligning research initiatives with market needs, Hassan Ahmad directly impacts the growth of the life sciences portfolio. The Chief Operating Officer - Getz Life coordinates with internal research departments to streamline the transition from laboratory development to large-scale manufacturing. Through strategic oversight of product lifecycles, Ahmad optimizes the delivery of specialized treatments to patients. This executive maintains focus on therapeutic efficacy and accessibility, ensuring that Getz Pharma remains at the forefront of medical advancement. Ultimately, the Chief Operating Officer - Getz Life drives the innovation agenda for the company.
Maria Batac - Maketing
Maria Batac, the Maketing at Getz Pharma, directs all global brand positioning and market outreach strategies. Overseeing the commercialization of the pharmaceutical portfolio, the Maketing ensures that affordable medicines reach target healthcare providers and patient populations effectively. This leadership role involves analyzing market dynamics to tailor promotional campaigns across various international regions. By leveraging data-driven insights, Maria Batac directly impacts the market penetration and brand recognition of the company. The Maketing coordinates with sales teams to align product messaging with clinical benefits and therapeutic value. Through strategic management of marketing channels, Batac enhances the visibility of the branded generic offerings. This executive maintains strong relationships with key stakeholders to foster long-term brand loyalty. Ultimately, the Maketing drives the commercial success of Getz Pharma by communicating the value of high-quality, affordable healthcare solutions to diverse global audiences, ensuring that the company maintains a strong competitive presence in the pharmaceutical industry.
Explore Leadership Teams in Manufacturing
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. Its marketed products include ONPATTRO (patisiran) for the treatment of the polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; AMVUTTRA for the treatment of hATTR amyloidosis with polyneuropathy in adults; GIVLAARI for the treatment of adults with acute hepatic porphyria; and OXLUMO for the treatment of primary hyperoxaluria type 1. In addition, the company develops patisiran for the treatment of transthyretin amyloidosis, or ATTR amyloidosis, with cardiomyopathy; cemdisiran to treat complement-mediated diseases; Belcesiran for the treatment of alpha-1 liver disease; Elebsiran to treat chronic HBV infection; Zilebesiran to treat hypertension; ALN-APP to treat Alzheimer's disease and cerebral amyloid angiopathy; and ALN-HSD to treat NASH. Further, it offers Fitusiran for the treatment of hemophilia, Inclisiran to treat hypercholesterolemia, lumasiran for the treatment of advanced PH1, and vutrisiran for the treatment of ATTR amyloidosis, which is in phase 3 clinical trial. Alnylam Pharmaceuticals, Inc. has strategic collaborations with Regeneron Pharmaceuticals, Inc. to discover, develop, and commercialize RNAi therapeutics for a range of diseases by addressing therapeutic targets expressed in the eye and CNS; and Roche to develop pharmaceutical products containing zilebesiran. It also has license and collaboration agreements with Novartis AG; Vir Biotechnology, Inc.; Dicerna Pharmaceuticals, Inc.; Ionis Pharmaceuticals, Inc.; and PeptiDream, Inc. The company was founded in 2002 and is headquartered in Cambridge, Massachusetts.
Company Leadership
CC
SR
Bausch & Lomb is a global eye health company that develops, manufactures and markets healthcare products. The company's products include over-the-counter products, dietary supplements, eye care products, ophthalmic pharmaceuticals, contact lenses, lens care products, ophthalmic surgical devices and instruments. They are based in Vaughan, Ontario, Canada.
Company Leadership JF
AG
Integrace Health is a therapy-focused healthcare company based in India, specializing in innovative solutions for Musculoskeletal Disorders, Pain Management, and Women's Health. Founded in 2018, it has quickly risen to become one of India's top 70 pharmaceutical companies, with five brands ranked #1 in their respective therapy areas. The company aims to significantly impact the health and well-being of the Indian population and envisions becoming a transformative force in the healthcare landscape by 2030. Integrace Health is committed to innovation, disciplined execution, and inspiring collaboration among its stakeholders.
Company Leadership KR
AN
SS
TriRx Pharmaceuticals is a contract development and manufacturing organization specializing in both non-sterile and sterile products, including animal health injectables and packaging solutions. The company offers a wide range of capabilities such as development and analytics, sterile and non-sterile manufacturing, and packaging services. With facilities located in Huntsville, Alabama, and Segré, France, TriRx aims to support customers' commercialization efforts across global markets. Their target clients include pharmaceutical companies looking for advanced solutions to bring their products to market.
Company Leadership TT
RM
JS
KL
Frequently Asked Questions Regarding Getz Pharma Top Executives and Leadership Team
